XTX Topco Ltd

Position in CRDF — Cardiff Oncology, Inc.

CIK 1828301 LONDON, X0

Position in CRDF

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$126,620

-$278,739 QoQ

Shares Held

97,400

-61.1% QoQ

Ownership

0.125%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#28

of 104 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $414,894,447 across 381 Biotechnology names. CRDF ranks #261 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	30,522	$19,031,687
2	ASND	Ascendis Pharma A/S	43,289	$11,546,042
3	BBIO	BridgeBio Pharma, Inc.	116,611	$8,685,187
4	MRNA	Moderna, Inc.	123,281	$8,633,368
5	JAZZ	Jazz Pharmaceuticals plc	30,496	$7,348,621
6	KYMR	Kymera Therapeutics, Inc.	61,501	$7,052,319
7	CYTK	Cytokinetics Inc	80,743	$6,878,496
8	PTCT	Ptc Therapeutics, Inc.	81,923	$6,682,459

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$126,620	97,400	-61.1%	Shares	Defined	2026-08-14
2026-03-31	$405,359	250,222	+14.1%	Shares	Defined	2026-05-15
2025-12-31	$616,393	219,357	+40.5%	Shares	Defined	2026-02-17
2025-09-30	$321,691	156,161	+19.8%	Shares	Defined	2025-11-14
2025-06-30	$410,608	130,352	+219.8%	Shares	Defined	2025-08-12
2024-12-31	$176,911	40,763	-66.1%	Shares	Defined	2025-02-13
2024-09-30	$321,425	120,384	+44.3%	Shares	Defined	2024-11-14
2024-06-30	$185,230	83,437	+149.4%	Shares	Defined	2024-08-12
2023-12-31	$49,510	33,453	-39.3%	Shares	Defined	2024-02-13
2022-06-30	$121,178	55,081	+119.0%	Shares	Defined	2022-08-15
2022-03-31	$62,381	25,154	+82.0%	Shares	Defined	2022-05-13
2021-09-30	$92,067	13,824	-7.1%	Shares	Defined	2021-11-12
2021-06-30	$98,998	14,887	—	Shares	Defined	2021-08-12
No filing history on record for this holder in this stock.